These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 36030843)
21. Theoretical evaluation of supersaturation of amorphous solid dispersion formulations with different drug/polymer combinations using mathematical modeling. Hirai D; Tsunematsu H; Kimura SI; Itai S; Fukami T; Iwao Y Int J Pharm; 2022 Sep; 625():122110. PubMed ID: 35970282 [TBL] [Abstract][Full Text] [Related]
22. An investigation into the influence of drug-polymer interactions on the miscibility, processability and structure of polyvinylpyrrolidone-based hot melt extrusion formulations. Chan SY; Qi S; Craig DQ Int J Pharm; 2015 Dec; 496(1):95-106. PubMed ID: 26428633 [TBL] [Abstract][Full Text] [Related]
23. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels. Sun DD; Ju TC; Lee PI Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548 [TBL] [Abstract][Full Text] [Related]
24. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form. Puri V; Dantuluri AK; Bansal AK J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949 [TBL] [Abstract][Full Text] [Related]
25. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives. Xie T; Taylor LS Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934 [TBL] [Abstract][Full Text] [Related]
26. Influence of mechanical and thermal energy on nifedipine amorphous solid dispersions prepared by hot melt extrusion: Preparation and physical stability. Ma X; Huang S; Lowinger MB; Liu X; Lu X; Su Y; Williams RO Int J Pharm; 2019 Apr; 561():324-334. PubMed ID: 30858115 [TBL] [Abstract][Full Text] [Related]
27. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium. Baghel S; Cathcart H; O'Reilly NJ Eur J Pharm Biopharm; 2016 Oct; 107():16-31. PubMed ID: 27378287 [TBL] [Abstract][Full Text] [Related]
28. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone). Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305 [TBL] [Abstract][Full Text] [Related]
29. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution. Purohit HS; Taylor LS Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218 [TBL] [Abstract][Full Text] [Related]
30. Enhanced dissolution rate of nimodipine through β-lactoglobulin based formulation. Leng D; Bulduk B; Anlahr J; Müllers W; Löbmann K Int J Pharm; 2023 Mar; 635():122693. PubMed ID: 36754186 [TBL] [Abstract][Full Text] [Related]
32. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films. Paudel A; Nies E; Van den Mooter G Mol Pharm; 2012 Nov; 9(11):3301-17. PubMed ID: 23009610 [TBL] [Abstract][Full Text] [Related]
33. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems. Tian Y; Jones DS; Andrews GP Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314 [TBL] [Abstract][Full Text] [Related]
34. Effects of Molecular Interactions on Miscibility and Mobility of Ibuprofen in Amorphous Solid Dispersions With Various Polymers. Xiang TX; Anderson BD J Pharm Sci; 2019 Jan; 108(1):178-186. PubMed ID: 30395836 [TBL] [Abstract][Full Text] [Related]
35. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective. Dukeck R; Sieger P; Karmwar P Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913 [TBL] [Abstract][Full Text] [Related]
36. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions. Luebbert C; Wessner M; Sadowski G Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155 [TBL] [Abstract][Full Text] [Related]
37. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify. Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852 [TBL] [Abstract][Full Text] [Related]